CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk› Healthcare› Panacea Biotec Ltd

Panacea Biotec Ltd

BSE 531349 PANACEABIO INE922B01023
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

19 filings · 4 material · busiest 2026-07-07

What it files

General6 Newspaper Publication4 SAST2 Board Outcome1 Results1 Order / Contract1 Insider / SAST1 Compliance Certificate1

Filings

19 in the window

  1. 18 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find enclosed newspaper copies of the public notice, requesting shareholders to register their email addresses with the Company in connection with ensuing AGM of the Company.

    Company Update / Newspaper Publication View filing →

  2. 14 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached of the extract of statement of Unaudited Financial Results for the quarter ended 30.06.2026, published on 14.08.2026.

    Company Update / Newspaper Publication View filing →

  3. 13 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026

    Please find attached Outcome of Board Meeting held on August 13, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  4. 13 August 2026

    Results

    Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2026

    Please find attached Unaudited Financial Results for quarter ended June 30, 2026.

    Result / Financial Results View filing →

  5. 12 August 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached newspaper copies regarding notice intimating the investors about the opening of Special Window for transfer and dematerialisation of physical shares.

    Company Update / Newspaper Publication View filing →

  6. 5 August 2026

    Order / Contract

    Award_of_Order_Receipt_of_Order

    We are delighted to inform you that the Company has received Letter of Award for supply of bivalent Oral Polio Vaccine (bOPV) to UNICEF in 10 and 20 dose presentation worth ~US$8.205 million ....

    Company Update / Award of Order / Receipt of Order View filing →

  7. 5 August 2026

    General

    Details Of Shares Dematerialized During July 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018

    Please find attached details of shares dematerialised during July 2026.

    Company Update / General View filing →

  8. 24 July 2026

    General

    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')

    The Company's wholly owned subsidiary, Panacea Biotec Pharma Ltd. has received a Show Cause Notice (SCN) dated July 23, 2026, from the office of the Assistant Commissioner, Goods and Services ....

    Company Update / General View filing →

  9. 16 July 2026

    General

    Updates In Relation To Receipt Of Four Awards Dated March 19, 2026 From The Presiding Officer (In The Rank Of Additional District Judge) Of Industrial Tribunal, S.A.S. Nagar, Mohali

    We would like to inform you that the Company has on July 16, 2026, filed appeal before the Hon'ble High Court of Punjab and Haryana, Chandigarh, against the remaining 4th award. The ....

    Company Update / General View filing →

  10. 13 July 2026

    Insider / SAST

    Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....

    Insider Trading / SAST / Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011 View filing →

  11. 7 July 2026

    General

    Demat Status Report For The Month Of June 2026

    We would like to inform that no share has been dematerialised during June 2026. A copy of the certificate obtained from the Company's RTA viz. Skyline Financial Services Pvt. Ltd. ....

    Company Update / General View filing →

  12. 7 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please find attached certificate dated July 01, 2026, issued by Skyline Financial Services Pvt. Ltd. , RTA under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, ....

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  13. 7 July 2026

    General

    Updates In Relation To Receipt Of Four Awards Dated March 19, 2026 From The Presiding Officer (In The Rank Of Additional District Judge) Of Industrial Tribunal, S.A.S. Nagar, Mohali

    Please find attached disclosure which is self explanatory

    Company Update / General View filing →

  14. 26 June 2026

    Trading Window

    Closure of Trading Window

    We would like to inform you that the trading window of the Company shall remain closed from July 01, 2026 till completion of 48 hours from the announcement of the Unaudited financial results ....

    Insider Trading / SAST / Closure of Trading Window View filing →

  15. 17 June 2026

    SAST

    Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Rajesh Jain

    Insider Trading / SAST / Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 View filing →

  16. 16 June 2026

    Newspaper Publication

    Newspaper Publication

    Please find attached newspaper copies regarding notice intimating the investors about the opening of a special window for transfer and dematerialisation of physical shares.

    Company Update / Newspaper Publication View filing →

  17. 8 June 2026

    Press Release

    Press Release / Media Release

    Panacea Biotec is pleased to inform the launch of the DENSTAR project which will work to advance the licensure of the dengue vaccine DengiAll in sub-Saharan Africa (sSA) and to facilitate ....

    Company Update / Press Release / Media Release View filing →

  18. 5 June 2026

    General

    Details Of Shares Dematerialized During May 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018

    Please find attached details of shares dematerialised during May 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

    Company Update / General View filing →

  19. 5 June 2026

    SAST

    Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....

    Insider Trading / SAST / Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011 View filing →